The information regarding the China testing has been out for weeks and had been discounted previously. This is clearly an over reaction. I'm out of the stock previously at $81 because though it may come back up it's subject to too much (even for me ) fluctuation, and even if the drug's successful GILD won't make a bucket of money with it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.